Cognitive Behavioural Therapy of Early Dementia
Cognitive Behavioural Resource-based Therapy of Early Dementia in the Everyday Setting
Lead Sponsor: Technische Universität München
|Source||Technische Universität München|
A randomized, controlled, parallel-group trial to evaluate the efficacy of a cognitive behavioral therapy for patients with early dementia.
The KORDIAL study is a randomized, controlled, parallel-group trial evaluating the efficacy of a cognitive behavioral therapy for patients at the early stage of Alzheimer's disease. The 3-month experimental intervention consists of 12 individual sessions with regular involvement of carers or other patient proxies. Strategies for improving the patient's coping ability and for enhancing their psychological well-being are combined. The primary outcome criterion is functioning in the everyday context after completion of the intervention and after another 6 months. The control condition will be treatment as usual. The study will be conducted in 5 university outpatient units and in 5 specialist offices.
|Start Date||April 2008|
|Completion Date||April 2010|
Intervention Type: Behavioral
Intervention Name: Cognitive behavioral therapy for early Alzheimer's disease
Description: 12 weekly individual sessions, total duration 3 months, regular involvement of patient's proxy ever second session. Intervention is manualized but is flexible with regard to individual resources and needs.
Arm Group Label: 1
Intervention Type: Other
Intervention Name: Control
Description: Patients and proxies who are assigned to treatment as usual
Arm Group Label: 2
Sampling Method: Non-Probability Sample
Inclusion Criteria: - Mild dementia (MMSE > 21) in Alzheimer's disease (ICD-10), proxy available Exclusion Criteria: - Acute of unstable psychiatric or physical disease, proxy unavailable - Participation in another trial
- Mild dementia (MMSE > 21) in Alzheimer's disease (ICD-10), proxy available
- Acute of unstable psychiatric or physical disease, proxy unavailable
- Participation in another trial
Minimum Age: 18 Years
Maximum Age: 95 Years
Healthy Volunteers: No
Name Title: Alexander Kurz M.D.
Organization: klinikum rechts der Isar
|Has Expanded Access||No|
|Study Design Info||
Time Perspective: Prospective